Allspring Global Investments Holdings LLC Sells 332 Shares of HCA Healthcare, Inc. $HCA

Allspring Global Investments Holdings LLC reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 3.9% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,103 shares of the company’s stock after selling 332 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in HCA Healthcare were worth $3,156,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. ORG Partners LLC increased its stake in HCA Healthcare by 27.9% in the 2nd quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after acquiring an additional 31 shares during the last quarter. Avantax Advisory Services Inc. increased its stake in HCA Healthcare by 0.4% in the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after acquiring an additional 32 shares during the last quarter. Glenview Trust co increased its position in shares of HCA Healthcare by 2.3% during the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock valued at $501,000 after purchasing an additional 32 shares during the last quarter. Horizon Investments LLC increased its position in shares of HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after purchasing an additional 33 shares during the last quarter. Finally, Sivia Capital Partners LLC increased its position in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Performance

NYSE HCA opened at $431.62 on Wednesday. The stock has a market cap of $101.00 billion, a P/E ratio of 18.14, a price-to-earnings-growth ratio of 1.37 and a beta of 1.40. The stock has a 50 day simple moving average of $411.88 and a two-hundred day simple moving average of $379.69. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $439.01.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the business posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Mizuho increased their price objective on HCA Healthcare from $425.00 to $475.00 and gave the company an “outperform” rating in a research report on Friday. UBS Group increased their target price on HCA Healthcare from $438.00 to $495.00 and gave the company a “buy” rating in a report on Tuesday, October 14th. Weiss Ratings restated a “buy (b-)” rating on shares of HCA Healthcare in a report on Wednesday, October 8th. Jefferies Financial Group increased their target price on HCA Healthcare from $400.00 to $485.00 in a report on Wednesday, October 15th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $444.00 target price on shares of HCA Healthcare in a report on Tuesday, October 7th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $437.19.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.